Background Over the past 2 decades, the use of intravenous ketamine infusions as a
treatment for chronic pain has increased dramatically, with wide variation in patient …

Neuropathic pain can develop after nerve injury, when deleterious changes occur in injured
neurons and along nociceptive and descending modulatory pathways in the central nervous …

There is tremendous interpatient variability in the response to analgesic therapy (even for
efficacious treatments), which can be the source of great frustration in clinical practice. This …

Neuropathic pain, pain arising as a direct consequence of a lesion or disease affecting the
somatosensory system, is relatively common, occurring in about 1% of the population …

Pain is the leading cause of medical consultations and occurs in 50–70% of emergency
department visits. To date, several drugs have been used to manage pain. The clinical use …

OBJECTIVES An increasing prevalence of pediatric asthma has led to increasing burdens of
critical illness in children with severe acute asthma exacerbations, often leading to …

Effects of the COVID-19 pandemic on chronic pain in Spain: a... : PAIN Reports Effects of the
COVID-19 pandemic on chronic pain in Spain: a scoping review : PAIN Reports International …

Ketamine is considered as a promising drug for many clinical applications even after five
decades since its discovery. Ketamine is a dissociative anesthetic agent with a variety of …

Aim: Patients with severe burns typically undergo multiple surgeries, and ketamine is often
used as part of the multimodal anesthetic regimen during such surgeries. The anesthetic …

Background: Combat injuries result in acute, severe pain. Early use of analgesia after injury
is known to be beneficial. Studies on prehospital analgesia in combat are limited and no …